Advent, Avista near deal for UCB's Kremers Urban, say sources-Reuters

A consortium of buyout firms Advent International Corp and Avista Capital Partners is in advanced talks to acquire UCB SA's (UCB.BR) U.S. generic drugs unit Kremers Urban Pharmaceuticals Inc, sources told Reuters.

DealsNorth AmericaUSBriefs